VCYT – veracyte, inc. (US:NASDAQ)
Stock Stats
News
Veracyte (VCYT) Valuation Check After Strong 2025 Earnings And Reaffirmed 2026 Growth Outlook [Yahoo! Finance]
Wisdom Bioscience Establishes Scientific Advisory Board to Advance Oral Cancer Diagnostics and Screening [Yahoo! Finance]
Veracyte (VCYT) had its price target raised by Needham & Company LLC from $44.00 to $48.00. They now have a "buy" rating on the stock.
Veracyte Q4 Earnings Call Highlights [Yahoo! Finance]
Veracyte outlines 10%–13% revenue growth for 2026 while advancing MRD and Prosigna launches [Seeking Alpha]
Form 144 VERACYTE, INC. Filed by: McGuire Annie
Form 144 VERACYTE, INC. Filed by: Leite John
Form 144 VERACYTE, INC. Filed by: Chambers Rebecca
Form 144 VERACYTE, INC. Filed by: Stapley Marc
Form 4 VERACYTE, INC. For: Mar 02 Filed by: Leite John
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.